Genome response to tissue plasminogen activator in experimental ischemic stroke

被引:13
|
作者
Jickling, Glen C. [1 ,2 ]
Zhan, Xinhua [1 ,2 ]
Ander, Bradley P. [1 ,2 ]
Turner, Renee [1 ,2 ]
Stamova, Boryana [1 ,2 ]
Xu, Huichun [1 ,2 ]
Tian, Yingfang [1 ,2 ]
Liu, Dazhi [1 ,2 ]
Davis, Ryan R. [1 ,2 ]
Lapchak, Paul A. [3 ]
Sharp, Frank R. [1 ,2 ]
机构
[1] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA
[2] Univ Calif Davis, MIND Inst, Sacramento, CA 95817 USA
[3] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA
来源
BMC GENOMICS | 2010年 / 11卷
关键词
BLOOD-BRAIN-BARRIER; GENE-EXPRESSION; INTRACEREBRAL HEMORRHAGE; MATRIX-METALLOPROTEINASE; THROMBOLYTIC THERAPY; CELLS; MATRIX-METALLOPROTEINASE-9; NEUTROPHILS; DISRUPTION; MONOCYTES;
D O I
10.1186/1471-2164-11-254
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Tissue plasminogen activator (tPA) is known to have functions beyond fibrinolysis in acute ischemic stroke, such as blood brain barrier disruption. To further delineate tPA functions in the blood, we examined the gene expression profiles induced by tPA in a rat model of ischemic stroke. Results: tPA differentially expressed 929 genes in the blood of rats (p <= 0.05, fold change >= vertical bar 1.2 vertical bar). Genes identified had functions related to modulation of immune cells. tPA gene expression was found to be dependent on the reperfusion status of cerebral vasculature. The majority of genes regulated by tPA were different from genes regulated by ischemic stroke. Conclusions: tPA modulates gene expression in the blood of rats involving immune cells in a manner that is dependent on the status of vascular reperfusion. These non-fibrinolytic activities of tPA in the blood serve to better understand tPA-related complications.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Tissue plasminogen activator-based nanothrombolysis for ischemic stroke
    Liu, Shan
    Feng, Xiaozhou
    Jin, Rong
    Li, Guohong
    EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (02) : 173 - 184
  • [2] Role of Tissue Plasminogen Activator in Acute Ischemic Stroke
    Hatcher, Molly A.
    Starr, Jessica A.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (03) : 364 - 371
  • [3] Combination Therapy of 17β-Estradiol and Recombinant Tissue Plasminogen Activator for Experimental Ischemic Stroke
    Liu, Ran
    Liu, Qing
    He, Shaoqing
    Simpkins, James W.
    Yang, Shao-Hua
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (03) : 1006 - 1012
  • [4] Vascular Protection to Increase the Safety of Tissue Plasminogen Activator for Stroke
    Ishrat, Tauheed
    Soliman, Sahar
    Guan, Weihua
    Saler, Mihaela
    Fagan, Susan C.
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) : 3677 - 3684
  • [5] Role of Tissue-Type Plasminogen Activator in Ischemic Stroke
    Suzuki, Yasuhiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 113 (03) : 203 - 207
  • [6] Hemorrhagic Transformation After Tissue Plasminogen Activator Treatment in Acute Ischemic Stroke
    Liu, Chengli
    Xie, Jie
    Sun, Shanshan
    Li, Hui
    Li, Tianyu
    Jiang, Chao
    Chen, Xuemei
    Wang, Junmin
    Le, Anh
    Wang, Jiarui
    Li, Zhanfei
    Wang, Jian
    Wang, Wei
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (03) : 621 - 646
  • [7] A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke
    del Rio-Espinola, Alberto
    Fernandez-Cadenas, Israel
    Giralt, Dolors
    Quiroga, Adoracion
    Gutierrez-Agullo, Maria
    Quintana, Manuel
    Fernandez-Alvarez, Patricia
    Domingues-Montanari, Sophie
    Mendioroz, Maite
    Delgado, Pilar
    Turck, Natacha
    Ruiz, Agustin
    Ribo, Marc
    Castellanos, Mar
    Obach, Victor
    Martinez, Sergi
    Mar Freijo, Mari
    Jimenez-Conde, Jordi
    Cuadrado-Godia, Elisa
    Roquer, Jaume
    Chacon, Pilar
    Marti-Fabregas, Joan
    Sanchez, Jean Charles
    Montaner, Joan
    ANNALS OF NEUROLOGY, 2012, 72 (05) : 716 - 729
  • [8] Acute ischemic stroke: improving access to intravenous tissue plasminogen activator
    Turner, Ashby C.
    Schwamm, Lee H.
    Etherton, Mark R.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (05) : 277 - 287
  • [9] Guidelines For Extending the Tissue Plasminogen Activator Treatment Window for Ischemic Stroke
    Asimos, Andrew W.
    STROKE, 2009, 40 (11) : E633 - E633
  • [10] Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    MAYO CLINIC PROCEEDINGS, 2014, 89 (07) : 960 - 972